ANEB
Price
$1.27
Change
+$0.20 (+18.69%)
Updated
Mar 10, 04:58 PM (EDT)
Capitalization
46.43M
58 days until earnings call
SRPT
Price
$99.66
Change
-$3.37 (-3.27%)
Updated
Mar 10, 03:15 PM (EDT)
Capitalization
10B
51 days until earnings call
Ad is loading...

ANEB vs SRPT

Header iconANEB vs SRPT Comparison
Open Charts ANEB vs SRPTBanner chart's image
Anebulo Pharmaceuticals
Price$1.27
Change+$0.20 (+18.69%)
Volume$600
Capitalization46.43M
Sarepta Therapeutics
Price$99.66
Change-$3.37 (-3.27%)
Volume$600
Capitalization10B
ANEB vs SRPT Comparison Chart
Loading...
ANEB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANEB vs. SRPT commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANEB is a Buy and SRPT is a Buy.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (ANEB: $1.05 vs. SRPT: $102.86)
Brand notoriety: ANEB: Not notable vs. SRPT: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANEB: 77% vs. SRPT: 140%
Market capitalization -- ANEB: $46.43M vs. SRPT: $9.67B
ANEB [@Biotechnology] is valued at $46.43M. SRPT’s [@Biotechnology] market capitalization is $9.67B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANEB’s FA Score shows that 0 FA rating(s) are green whileSRPT’s FA Score has 0 green FA rating(s).

  • ANEB’s FA Score: 0 green, 5 red.
  • SRPT’s FA Score: 0 green, 5 red.
According to our system of comparison, ANEB is a better buy in the long-term than SRPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANEB’s TA Score shows that 3 TA indicator(s) are bullish while SRPT’s TA Score has 4 bullish TA indicator(s).

  • ANEB’s TA Score: 3 bullish, 5 bearish.
  • SRPT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SRPT is a better buy in the short-term than ANEB.

Price Growth

ANEB (@Biotechnology) experienced а -14.63% price change this week, while SRPT (@Biotechnology) price change was -3.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.83%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.34%.

Reported Earning Dates

ANEB is expected to report earnings on May 08, 2025.

SRPT is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (+0.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRPT($10B) has a higher market cap than ANEB($46.4M). SRPT YTD gains are higher at: -15.404 vs. ANEB (-37.500). SRPT has higher annual earnings (EBITDA): 187M vs. ANEB (-7.43M). SRPT has more cash in the bank: 1.2B vs. ANEB (15M). SRPT has higher revenues than ANEB: SRPT (1.64B) vs ANEB (0).
ANEBSRPTANEB / SRPT
Capitalization46.4M10B0%
EBITDA-7.43M187M-4%
Gain YTD-37.500-15.404243%
P/E RatioN/A44.03-
Revenue01.64B-
Total Cash15M1.2B1%
Total DebtN/A1.4B-
FUNDAMENTALS RATINGS
SRPT: Fundamental Ratings
SRPT
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANEBSRPT
RSI
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 7 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
86%
Bullish Trend 7 days ago
79%
Momentum
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
77%
MACD
ODDS (%)
N/A
Bearish Trend 7 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 7 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 7 days ago
73%
Advances
ODDS (%)
N/A
Bullish Trend about 1 month ago
75%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 12 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
89%
Bullish Trend 7 days ago
86%
Aroon
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 7 days ago
74%
View a ticker or compare two or three
Ad is loading...
ANEB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X87222.1950001156.515600
+1.34%
Bitcoin cryptocurrency
GME24.30-0.10
-0.41%
GameStop Corp
AAPL235.93-2.10
-0.88%
Apple
SPY576.86-6.91
-1.18%
SPDR® S&P 500® ETF Trust
TSLA272.04-12.61
-4.43%
Tesla

ANEB and

Correlation & Price change

A.I.dvisor tells us that ANEB and ABCZF have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANEB and ABCZF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANEB
1D Price
Change %
ANEB100%
-5.41%
ABCZF - ANEB
31%
Poorly correlated
N/A
ALDX - ANEB
28%
Poorly correlated
+1.82%
SRPT - ANEB
26%
Poorly correlated
+1.62%
RLAY - ANEB
23%
Poorly correlated
-0.31%
IMUC - ANEB
23%
Poorly correlated
N/A
More

SRPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRPT has been loosely correlated with BPMUF. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if SRPT jumps, then BPMUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRPT
1D Price
Change %
SRPT100%
+1.62%
BPMUF - SRPT
52%
Loosely correlated
N/A
AAVXF - SRPT
45%
Loosely correlated
N/A
ARWR - SRPT
36%
Loosely correlated
-3.39%
FATE - SRPT
32%
Poorly correlated
-7.77%
RCKT - SRPT
31%
Poorly correlated
-1.48%
More